PROSTATE SCREENING QUALITY OF LIFE REDUCTIONS

PROSTATE SCREENING QUALITY OF LIFE REDUCTIONS outweigh the 1-2 day increases in life expectancy realized through screening, Murray Krahn, MD, University of Toronto, et al., conclude in a study published in the Sept. 14 issue of the Journal of the American Medical Association. Using information obtained from existing databases, the authors say their "analysis shows that screening may marginally reduce prostatic cancer mortality for men between the ages of 50 and 70 years, but it suggests that the benefits of reduced prostatic cancer mortality are more than offset by the morbidity of prostatic cancer treatment."